Skip to content
thestock.space

On 6 Nov 2026, Vijaya Diagnostic Centre was priced at ₹1,468.60, or 74.4× trailing earnings, against an industry P/E of 52.8×. It earns ROCE of 19% and ROE of 21%, and sales and net profit grew 21% and 27% a year over 3 years. Its dividend yield is 0.1%, and debt is 0.48× equity. It is a small-cap company with a market cap of ₹15,126 Cr, ranked 4th of 18 Diagnostics & Research companies by market cap; the shares rose 40% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Sep 2026.How we calculate this

past year
Open
₹1,430.00
Day high
₹1,478.00
Day low
₹1,424.00
Prev. close
₹1,437.70
Volume
1.4 L

Health check

3 good · 2 fair · 1 to check
  • ReturnsAhead

    +40.2% over a year, better than 6 of 7 peers.

  • Price tagPricier

    P/E 74.4 vs industry 52.8.

  • GrowthSteady

    Sales +21.0%, profit +26.9% a year over 3 years.

  • ProfitabilityAverage

    ROCE 19.1% vs peer median 18.1%.

  • Balance sheetSolid

    Debt 0.48× equity, interest covered 8.4×, Piotroski 7 of 9.

  • Red flagsNone found

    No warning signs in the headline numbers.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Diagnostics & Research

17 listed peers. Screen the industry

Small cap

₹15,126 Cr, #4 of 18 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Sep 2026: sales ₹911 Cr · profit ₹204 Cr
Market cap
₹15,126 Cr
Small cap
P/E
74.4
Industry 52.8
Price to book
14.29
Peers 7.17
Dividend yield
0.14%
ROE
21.2%
Peers 15.1%
ROCE
19.1%
Peers 18.1%
Debt to equity
0.48
Debt ₹509 Cr
EPS (TTM)
₹19.75
Face value ₹1
OPM (TTM)
43.1%
Net margin 22.4%
Sales growth
+29.2%
Latest quarter vs a year ago
Profit growth
+37.1%
Latest quarter vs a year ago
Price to sales
16.60
EV/EBITDA 43.2

Strengths and risks

Strengths

  • Return on equity of 21.2%.
  • Quarterly profit up 37.1% on a year ago.
  • Quarterly sales up 29.2% on a year ago.
  • Net margin of 22.4%.
  • Positive operating cash flow in each of the last 4 years.

No obvious red flags in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About Vijaya Diagnostic Centre

Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, and molecular diagnostics; radiology services, such as CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, and gastroenterology; and advance radiology service comprising nuclear medicine, positron…

Headquarters
Hyderabad
Employees
2,507
Sector
Healthcare
ISIN
INE043W01024
Website
vijayadiagnostic.com

Price range

52 weeks

₹848.00₹1,593.60

Today

₹1,424.00₹1,478.00
Avg volume (3M)
1.6 L
1-year return
plus 40.2%
From 52-week high
minus 7.8%

Analyst consensus

10 analysts
No consensusMean target ₹1,554.80 plus 5.9%

Target range, with today’s price

Low ₹1,400.00High ₹1,700.00

Consensus from Yahoo Finance. Not a recommendation.

Peers · Diagnostics & Research

Compare with peersScreen the whole industry
Company
SAILIFESai Life Sciences1,785.10plus 11.95%37,929101.515.2218.1%15.1%28.7%21.3%226.8%0.00%plus 72.7%
LALPATHLABDr. Lal Path Labs1,970.00plus 0.16%32,94156.511.9925.7%22.6%30.2%11.1%28.3%1.02%plus 24.7%
SYNGENESyngene International417.30plus 0.77%16,77290.33.468.3%3.9%25.7%5.4%−12.0%0.30%minus 36.0%
VIJAYAVijaya Diagnostic Centre1,468.60plus 2.15%15,12674.414.2919.1%21.2%43.1%21.0%26.9%0.14%plus 40.2%
METROPOLISMetropolis Healthcare568.75minus 0.39%11,80352.87.1715.7%14.6%21.7%12.7%10.0%0.35%plus 12.5%
THYROCAREThyrocare Technologies493.10plus 0.68%7,84855.014.7533.8%26.4%32.2%16.7%36.2%1.89%plus 8.3%
VIMTALABSVimta Labs496.45minus 2.14%2,21927.94.5221.0%17.7%34.7%8.9%17.2%0.40%minus 23.3%
SURAKSHASuraksha Diagnostic333.55plus 0.68%1,73748.57.0714.7%14.1%21.8%17.7%70.3%0.15%plus 2.2%
Median of 7 peers–0.68%11,80355.07.1718.1%15.1%28.7%12.7%28.3%0.35%8.3%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Dec 25Mar 26Jun 26Sep 26
188205219231255
115119124132143
73.586.195.598.5113
39.1%41.9%43.5%42.7%44.1%
75.12.48.55
7.58.69.31111.4
20.924.324.325.126.9
52.258.264.370.979.4
26.1%25.8%25.4%25.2%25.1%
38.643.247.953.159.5
3.754.194.655.155.76

Sep 25 not reported by the data source.

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+21.0%
Profit CAGR 3Y
+26.9%
EPS CAGR 3Y
+26.7%
ROE
21.2%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
459548681814
–+19.3%+24.4%+19.5%
277327408477
182221273337
39.7%40.3%40.1%41.4%
7.84.44.14.5
19.42224.531.3
61.75770.691.8
4.712.41114.4
114159193233
24.9%24.6%25.6%25.7%
84.6119144173
–+40.4%+21.0%+20.3%
8.2611.5913.9716.79

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
10.210.210.310.3
535647789947
248259320423
61.166.4155127
8539831,2741,507
550615802977
33.612.578.647.8
0.40.40.231.1
255185281288
13.9170111163
8539831,2741,507

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
165183224271
−110−142−182−174
−41.9−44.5−52−69.5
13.1−3.6−9.526.9
−125−88−95.6−183
39.895.312987.9
−10.2−10.2−10.3−20.5

Shareholding pattern

Source: NSE filings
52.5%
promoters
  • Promoters52.46%
  • Public47.54%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202652.46%47.54%minus 0.05
30 Jun 202652.51%47.49%0.00
31 Mar 202652.51%47.49%minus 0.09
31 Dec 202552.60%47.40%0.00
30 Sep 202552.60%47.40%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you